Trial Site Detail
Drug: |
Avapritinib or Regorafenib |
|||
|---|---|---|---|---|
Trial: |
(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Active, not recruiting |
|||
Texas Oncology - Baylor Charles A Sammons Cancer Center |
Principal Investigator: |
Andrew D. McCollum |
|---|---|
Contact: |
|
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Texas Oncology - Baylor Charles A Sammons Cancer Center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.